Cargando…
Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
Autores principales: | Lozano‐Rodríguez, Roberto, Terrón‐Arcos, Verónica, Montalbán‐Hernández, Karla, Casalvilla‐Dueñas, José Carlos, Bergón‐Gutierrez, Marta, Pascual‐Iglesias, Alejandro, Quiroga, Jaime Valentín, Aguirre, Luis A., Pérez de Diego, Rebeca, Vela‐Olmo, Carmen, López‐Morejón, Lissette, Martín‐Quirós, Alejandro, del Balzo‐Castillo, Álvaro, Peinado‐Quesada, María A., García‐Garrido, Miguel A., Gómez‐Lage, Laura, Herrero‐Benito, Carmen, Llorente‐Fernández, Irene, Martín‐Miguel, Gema, Torrejón, Margarita, Cubillos‐Zapata, Carolina, del Fresno, Carlos, Avendaño‐Ortiz, José, López‐Collazo, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092002/ https://www.ncbi.nlm.nih.gov/pubmed/35538923 http://dx.doi.org/10.1002/ctm2.869 |
Ejemplares similares
-
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2023) -
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2022) -
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2022) -
The immune checkpoints storm in COVID‐19: Role as severity markers at emergency department admission
por: Avendaño‐Ortiz, José, et al.
Publicado: (2021) -
Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer
por: Montalbán-Hernández, Karla, et al.
Publicado: (2022)